Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for RIGEL PHARMACEUTICALS INC Common Stock (RIGL).
- Disclosed ownership: 0.7%.
- Date of event: 30 Sep 2025.
MORGAN STANLEY - 30 Sep 2025 SCHEDULE 13G/A Report for RIGEL PHARMACEUTICALS INC Common Stock (RIGL)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- RIGL
- Shares outstanding
- 16,629,429 shares
- Disclosed Ownership
- 116,406 shares
- Ownership
- 0.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Oct 2025, 16:15:56 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 0.7% ownership in RIGEL PHARMACEUTICALS INC Common Stock (RIGL) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Oct 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.7% | 116,406 | 0 | 113,510 | Chris O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 0.4% | 71,545 | 0 | 71,545 | Chris O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |